Astrid Pavlovsky
@AstridPavlovsky
Together we lead, we learn, we lift each other up. Thank you to all who joined our WiL gathering at #18ICML — an inspiring evening filled with connection, purpose, and power. Let’s keep building this global community, one voice at a time. 🌍 #womeninhematology #ICML2025
Big news: Mosun-Pola is superior to chemotherapy for patients with aggressive lymphoma. At @icmlugano, I was honored to present—on behalf of an incredible team of global coauthors—the SUNMO trial: ➡️ First positive Phase III trial in this space without conventional chemotherapy
Check out our 2 posters: Long term follow up of Pet adapted therapy in all stages of HL and RWE of use of consolidation of BV post auto. @FiadLorena. Nice visita from @CarlosChiattone and @Evadodo23 @icmlugano #ICML2025
Impressive response rates with #epcoritamab + R-ICE IN R/R DLBCL with ORR 87% and CR rate of 65%. Also in patients with early relapses within 12m 1L therapy #hematology #lymphoma #lymsm
Save the date! Our next webinar series will run throughout July - stay tuned for updates
CONGRESS | #EHA2025 | POSTER @AstridPavlovsky presented long-term findings from the GATLA LH-05 trial evaluating PET-CT-adapted treatment following 3 cycles of ABVD in patients with classical Hodgkin #lymphoma (N = 557). PET3-negative patients had significantly better PFS at 60…
Here we reviewed molecular advances in MDS with a Latin American Perspective mdpi.com/3340472 #mdpigenes vía @Genes_MDPI
Challenges in managing and reporting adverse events in haematological malignancies in low-income and middle-income countries - The Lancet Haematology thelancet.com/journals/lanha…
This is a crucial issue that requires attention. Waiting an entire year for a response should not be acceptable, but unfortunately, it happens too often. In Latin America, only 14% of cancer research papers are published the same year they are completed. It is necessary to…
Big things are happening in Buenos Aires this week! 🧬 GATMO 2025 is just around the corner! 📅 May 23–24 | 📍CABA We can’t wait to welcome you! (🥳) Let’s talk science, share ideas & have some fun! ✨ See you there! #GATMO2025 #NextGenHematology #Networking
Sharing ideas to acheive international colaboración in linfomas. The aim is to develop relevant information to try to improve the prognosis of our patients. Thank you @massimofederico @StefanoLuminari @AndresFerreri @mariagomesdasouza
Great experience: Excelent lectures and case discussions with outsatnding people in abeautiful Rio de Janeiro.
Join us next week for the kickoff of our 14th webinar series "Demystifying Pharma"!
@LymphomaEx took a great step by incentivizing us to discuss what the standards in Latin America should be. It is amazing to witness the efforts of colleagues across the world in bringing the best care to patients. Congrats on an amazing conference! @iHematologo @cytohance…
Nuevamente fue una gran experiencia! Gracias, nos vemos en #LEx26 !
Muchas gracias!
Nuevamente fue una gran experiencia! Gracias, nos vemos en #LEx26 !
Feliz! FeLEx! Gracias por otro evento maravilloso! LEx 2025 @LymphomaEx
Waking up to enjoy high quality discusions on HL and DLBCL with great collegues @LymphomaEx #Lex25
Moreover, we need to highlight the wondeful women (#WiL) that ran the show here @laura_korin @AstridPavlovsky @silcugliari Carolina Mauad Nancy Cristaldo Marta Zerga @SchutzNatalia and many others. An honor to share the podium with you!